Janssen, “We’ll carry out extensive & global Phase II clinical trial of Hanmi Pharm’s obesity and diabetes biologic”
Hanmi Pharm’s new obesity & diabetes biologic being developed by Janssen HM12525A(Janssen Code Name: JNJ-64565111) will additionally take an extensive global Phase II clinical trial.
This Phase II clinical trial will evaluate safety and efficacy on 188 extreme obesity patients with diabetes. Ja...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
